comparemela.com
Home
Live Updates
Presenterindy Zhang - Breaking News
Pages:
Latest Breaking News On - Presenterindy zhang - Page 1 : comparemela.com
Enanta Pharmaceuticals, Inc : Enanta Pharmaceuticals to Present New Data for EDP-235, its 3CL Protease Inhibitor, in Development as an Oral, Once-Daily Treatment for COVID-19, at the 36th International Conference on Antiviral Research
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL
Dennis riedl
Presenterindy zhang
Jennifer viera
Michael rhodin
Presentertessa cressey
International conference on antiviral research
Enanta pharmaceuticals inc
Enanta pharmaceuticals
International conference
Antiviral research
Centre de congres lyon
Lyon convention center
Central european time
Suppresses viral replication
Oral antiviral
Demonstrates excellent penetration
vimarsana © 2020. All Rights Reserved.